Stay updated with breaking news from அறிவியல் மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VYNE Therapeutics Inc. (VYNE) Q2 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Lucira Health, Inc. (LHDX) Q2 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Celldex Therapeutics Announces Pricing of Upsized $250 Million Public Offering of Common Stock Celldex Therapeutics, Inc.July 14, 2021 GMT HAMPTON, N.J., July 13, 2021 (GLOBE NEWSWIRE) Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an underwritten public offering of 5,952,381 shares of its common stock at a public offering price of $42.00 per share. In connection with the offering, Celldex has granted the underwriters a 30-day option to purchase up to an additional 892,857 shares of common stock at the public offering price, less underwriting discounts and commissions. ....
HAMPTON, N.J., July 13, 2021 (GLOBE NEWSWIRE) Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (NASDAQ:CLDX) today announced the pricing of an underwritten public offering of 5,952,381 shares of its common stock at a public offering price of $42.00 per share. In connection with the offering, Celldex has granted the underwriters a 30-day option to purchase up to an additional 892,857 shares of common stock at the public offering price, less underwriting discounts and commissions. Jefferies, SVB Leerink, Guggenheim Securities and Cantor are acting as the joint book-running managers for the offering. LifeSci Capital LLC and H.C. Wainwright & Co. are acting as co-lead managers for the offering. ....
Celldex Therapeutics Announces Pricing of Upsized $250 Million Public Offering of Common Stock July 13, 2021 20:30 ET | Source: Celldex Therapeutics, Inc. Celldex Therapeutics, Inc. Needham Heights, Massachusetts, UNITED STATES HAMPTON, N.J., July 13, 2021 (GLOBE NEWSWIRE) Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an underwritten public offering of 5,952,381 shares of its common stock at a public offering price of $42.00 per share. In connection with the offering, Celldex has granted the underwriters a 30-day option to purchase up to an additional 892,857 shares of common stock at the public offering price, less underwriting discounts and commissions. Jefferies, SVB Leerink, Guggenheim Securities and Cantor are acting as the joint book-running managers for the offering. LifeSci Capital LLC and H.C. Wainwright & Co. are acting as co-l ....